MapLight Therapeutics to Participate in Jefferies Biotech on the Beach Summit, Leerink Global Healthcare Conference, and Stifel Virtual CNS Forum

Reuters
Mar 02
MapLight <a href="https://laohu8.com/S/LENZ">Therapeutics</a> to Participate in Jefferies Biotech on the Beach <a href="https://laohu8.com/S/SMMT">Summit</a>, Leerink Global Healthcare Conference, and <a href="https://laohu8.com/S/SFB">Stifel</a> Virtual CNS Forum

MapLight Therapeutics Inc. said its management team will participate in three upcoming investor conferences: Jefferies 2026 Biotech on the Beach Summit on March 10, 2026 (1x1 meetings), Leerink 2026 Global Healthcare Conference on March 11, 2026 (presentation and 1x1 meetings), and the Stifel 2026 Virtual CNS Forum on March 18, 2026 (presentation and 1x1 meetings). Webcasts and archived recordings, where available, will be posted at https://ir.maplightrx.com/news-events/events-presentations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maplight Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603020700PRIMZONEFULLFEED9663622) on March 02, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10